Global Shingles Vaccine Market Size By Product Type, By Vaccine Type, By Distribution Channel, By Geographic Scope And Forecast

Shingles Vaccine Market Size And Forecast

Shingles Vaccine Market size was valued at USD 4.6 Billion in 2024 and is projected to reach USD 6.7 Billion by 2031, growing at a CAGR of 11.31% from 2024 to 2031

Global Shingles Vaccine Market Drivers

The market drivers for the Shingles Vaccine Market can be influenced by various factors. These may include

• Ageing Population The chance of shingles rising with age of the world’s population fuels the need for vaccinations to stop the illness.
• Expanding Knowledge The market may expand as more people and medical professionals realise how important vaccinations are for preventing shingles.
• Government Measures And Immunisation Programmes The adoption of shingles vaccinations can be increased by government measures encouraging adult vaccination programmes, particularly for elderly persons.
• Strong Incidence of Herpes Zoster The strong incidence of herpes zoster infections, particularly in elderly people or those with impaired immune systems, generates a substantial market need for shingles vaccinations.
• Development Of Newer, More Efficient Vaccinations with longer protection durations and higher efficiency are examples of how vaccine technology advancements can propel market expansion.
• Development of the Healthcare Infrastructure Especially in developing countries, better healthcare infrastructure can boost vaccination access and propel market growth.
• Increasing Healthcare Expense The Shingles Vaccine Market may expand as a result of rising healthcare expenditure, especially for preventative healthcare measures.
• Risk Factors Knowledge As knowledge of the risk factors linked to shingles, such stress and immunosuppression, increases, so does the need for vaccination as a preventive intervention.
• Insurance Coverage and Reimbursement Policies Better insurance coverage and more favourable vaccination reimbursement policies can lower the cost and increase accessibility of shingles vaccinations, therefore promoting market expansion.
• COVID-19 Pandemic The COVID-19 pandemic has raised consciousness of infectious diseases and the value of vaccination, which may result in a greater acceptance and use of shingles vaccinations as part of preventive healthcare measures.

Global Shingles Vaccine Market Restraints

Several factors can act as restraints or challenges for the Shingles Vaccine Market. These may include

• High Cost Especially in areas where healthcare costs are not completely covered by insurance or government programmes, the price of shingles vaccinations might be a major obstacle. This might restrict which demographic groups can get the vaccination.
• Limited Awareness The market may grow more slowly if the general public and medical experts are unaware of shingles and the value of vaccine. Many persons could not be aware that they are at danger or might misjudge how serious the illness is.
• Despite The Shingles Vaccinations’ Demonstrated Success some people may still have doubts about their safety and efficacy. Overcoming this limitation will need addressing these issues through communication and education.
• Logistics Especially in areas with little infrastructure, the distribution and storage needs for vaccinations, particularly those needing cold chain management, can be logistically difficult.
• Regulatory hurdles Manufacturers wishing to obtain clearance in several jurisdictions may have to pay more or wait longer to enter the market because regulatory approval procedures and requirements can differ between nations.
• The Market Share Of Branded Products may be impacted by pricing pressures as patents expire and generic copies of the shingles vaccine become accessible.
• Prevalence of Other Vaccines In areas with low resources, shingles vaccination campaigns may receive less attention and resources as other vaccines aimed at diseases with higher prevalence or death rates take precedence.
• Uneven Access Uneven distribution of shingles vaccinations might arise from differences in socioeconomic classes’ and urban and rural areas’ access to healthcare facilities and vaccinations, therefore restricting the possibility for market expansion.
• The Difficulties In Identifying high-risk groups Reaching and identifying high-risk groups, such elderly people and those with immunological disorders, might be difficult because of things like inadequate outreach initiatives and healthcare infrastructure.

Global Shingles Vaccine Market Segmentation Analysis

The Global Shingles Vaccine Market is Segmented on the basis of Product Type, Vaccine Type, Distribution Channel, And Geography.

Shingles Vaccine Market, By Product Type

• Focus This segment categorizes the market based on the specific shingles vaccines available.
• Description It identifies the major players in the market, including established vaccines like Zostavax (live attenuated) and Shingrix (recombinant), along with any emerging or developmental vaccines.

Shingles Vaccine Market, By Vaccine Type

• Focus This segment delves into the technology used to create the vaccines.
• Description It differentiates between two main types
• Recombinant Vaccine This advanced method uses genetically engineered components of the varicella-zoster virus to stimulate the immune system. Shingrix is a prime example.
• Live Attenuated Vaccine This traditional approach utilizes a weakened form of the virus itself to trigger immunity. Zostavax falls under this category.

Shingles Vaccine Market, By Distribution Channel

• Focus This segment analyzes the pathways through which shingles vaccines reach patients.
• Description It identifies the key channels involved in vaccine distribution, such as
• Hospital Pharmacies These pharmacies supply vaccines to healthcare facilities within hospitals.
• Retail Pharmacies These are community pharmacies where individuals can directly access shingles vaccines with a prescription.
• Clinics Many clinics stock and administer shingles vaccines during patient visits.
• Other Channels This may encompass online pharmacies or specialized vaccination centers offering shingles vaccines.

Shingles Vaccine Market, By Geography

• North America Market conditions and demand in the United States, Canada, and Mexico.
• Europe Analysis of the Shingles Vaccine Market in European countries.
• Asia-Pacific Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa Examining market dynamics in the Middle East and African regions.
• Latin America Covering market trends and developments in countries across Latin America.

Key Players

The major players in the Shingles Vaccine Market are

• CanSino Biologics Inc.
• Curevo Inc.
• GlaxoSmithKline Plc
• Merck and Co. Inc.
• SK Bioscience
• Vaccitech
• Inovio Pharmaceuticals Inc.
• Precision Vax LLC
• Sanofi

Report Scope

 Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.